Cited by 118Pharmacogenetics and Drug MetabolismEstrogen and related hormone effectsMetal-Catalyzed Oxygenation Mechanisms

The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.

Role of Polymorphic Human Cytochrome P450 Enzymes in Estrone Oxidation

Cribb, Alastair E., Knight, M. Joy, Dryer, Dagny, Guernsey, Judy, Hender, Kimberly, Tesch, Marvin, Saleh, Tarek M.·2006·Cancer Epidemiology, Biomarkers & Prevention

DOI 10.1158/1055-9965.epi-05-0801

Open this paper in CoChat — free account

Abstract

Estrogen and its metabolites are believed to play important roles in breast cancer. The influence of genetic polymorphisms in the enzymes responsible for formation and disposition of estrogen on breast cancer risk may shed light on the importance of estrogen metabolites in this disease. However, for such studies to be valid, it is important to correctly identify the enzymes involved in estrogen bioactivation. Therefore, we assessed the human cytochrome P450-dependent oxidation of estrone using substrate concentrations that more closely approximate the maximum expected concentrations in breast tissue. The in vitro metabolism of estrone by recombinant human cytochrome P450 enzymes and human liver microsomes was studied. The formation of estrone metabolites (2-hydroxyestrone, 4-hydroxyestrone, and 16alpha-hydroxyestrone) was monitored by high-performance liquid chromatography. 2-Hydroxyestrone formation was catalyzed predominantly by CYP1A2, CYP1A1, and CYP1B1 enzymes; 4-hydroxyestrone formation was catalyzed predominantly by CYP1B1, CYP1A2, and CYP1A1 enzymes; and 16alpha-hydroxyestrone formation was catalyzed predominantly by CYP2C19, CYP1A1, and CYP3A5. This study confirms the important role of members of the CYP1 family in the 2-hydroxylation and 4-hydroxylation of estrone, but the enzymes identified as responsible for the 16alpha-hydroxylation of estrone are different from those previously identified. The relative importance of these enzymes in vivo would depend on the specific tissue expression of the enzymes. These enzymes are all known to be genetically variant in the human population, and additional studies to assess the role CYP1A2, CYP2C19, and CYP3A5 in breast cancer risk are indicated.

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-05-0801

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785 · cited 1×
“When the relative intrinsic clearances of the various enzymes were corrected for the differing expression levels in the typical human liver (51, 52), the predicted contribution from CYP1A2 was eight times higher than other CYP enzymes (Table 5).”
Background
Production and Actions of Estrogens
Gruber, C. J., Tschugguel, W., Schneeberger, C., & Huber, J. C. (2002) · New England Journal of Medicine · doi:10.1056/nejmra000471 · Cited by 1,091
Functional role of estrogen metabolism in target cells: review and perspectives
Zhu, B. T. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.1 · Cited by 970
Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women
Veronesi, U., Maisonneuve, P., Costa, A., Sacchini, V., MALTONI, C., Robertson, C. E., Rotmensz, N., & Boyle, P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)85011-3 · Cited by 799
Molecular Mechanisms of Estrogen Carcinogenesis
Yager, J. D., & Leihr, J. G. (1996) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001223 · Cited by 671
17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.
Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., & Sutter, T. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9776 · Cited by 631
Characterization of the Oxidative Metabolites of 17β-Estradiol and Estrone Formed by 15 Selectively Expressed Human Cytochrome P450 Isoforms
Lee, A. J., Cai, M. X., Thomas, P. E., Conney, A. H., & Zhu, B. T. (2003) · Endocrinology · doi:10.1210/en.2003-0192 · Cited by 457
Endogenous concentration and subcellular distribution of androgens in normal and malignant human breast tissue.
van Landeghem, A. A. J., Poortman, J., Nabuurs, M., & Thijssen, J. H. H. (1985) · PubMed · Cited by 448
P450 enzymes of estrogen metabolism
Martucci, C. P., & Fishman, J. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90057-k · Cited by 389
Discussion
Rodrigues, A. D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00268-8 · Cited by 370

Show all 70 references

Research works printed but not linked: 1

Rodrigues AD. Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes. Biochem Pharmacol 1999;57:465–80.

Sorted by citations

The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis
Nebert, D. W., & Dalton, T. P. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2015 · Cited by 985
Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
“CYP3A4 is the major enzyme responsible for the 16αhydroxylation of estrone in adults, though CYP1A1, CYP2C19 and CYP3A5 can also catalyze the reaction [315,316].”
Estrogen metabolism and breast cancer
Samavat, H., & Kurzer, M. S. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.04.018 · Cited by 401
Contributions of Human Enzymes in Carcinogen Metabolism
Rendić, S., & Guengerich, F. P. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300132k · Cited by 281
Potential Mechanisms of Estrogen Quinone Carcinogenesis
Bolton, J. L., & Thatcher, G. R. J. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700191p · Cited by 242
The structural biology of oestrogen metabolism
THOMAS, M. P., & Potter, B. V. L. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.12.014 · Cited by 181
MECHANISMS IN ENDOCRINOLOGY: Estradiol as a male hormone
Russell, N., & Grossmann, M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-1000 · Cited by 145
Estrogens and the risk of breast cancer: A narrative review of literature
Al‐Shami, K., Awadi, S., Khamees, A., Alsheikh, A. M., Al-Sharif, S., Bereshy, R., Al-Eitan, S. F., Banikhaled, S. H., Al-Qudimat, A. R., Al‐Zoubi, R. M., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20224 · Cited by 143
Regioselective hydroxylation of steroid hormones by human cytochromes P450
Niwa, T., Murayama, N., Imagawa, Y., & Yamazaki, H. (2015) · Drug Metabolism Reviews · doi:10.3109/03602532.2015.1011658 · Cited by 121
Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women
Sangrajrang, S., Sato, Y., Sakamoto, H., Ohnami, S., Laird, N. M., Khuhaprema, T., Brennan, P., Boffetta, P., & Yoshida, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24434 · Cited by 112
The Role of CYP3A in Health and Disease
Klyushova, L. S., Perepechaeva, M. L., & Grishanova, A. Y. (2022) · Biomedicines · doi:10.3390/biomedicines10112686 · Cited by 109
Berries and Ellagic Acid Prevent Estrogen-Induced Mammary Tumorigenesis by Modulating Enzymes of Estrogen Metabolism
Aiyer, H. S., & Gupta, R. C. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0260 · Cited by 84
Human Family 1–4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update
Rendić, S., & Guengerich, F. P. (2021) · Archives of Toxicology · doi:10.1007/s00204-020-02971-4 · Cited by 85
Role of dietary bioactive natural products in estrogen receptor-positive breast cancer
Bak, M. J., Das Gupta, S., Wahler, J., & Suh, N. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.03.001 · Cited by 80
CYP2C19*17 is associated with decreased breast cancer risk
Justenhoven, C., Hamann, U., Pierl, C. B., Baisch, C., Harth, V., Rabstein, S., Lotz, A., Pesch, B., Brüning, T., Winter, S., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0076-4 · Cited by 77
Review. Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer.
Bradlow, H. L. (2008) · PubMed · Cited by 76
In Vitro Cytochrome P450-Mediated Metabolism of Exemestane
Kamdem, L. K., Flockhart, D. A., & Desta, Z. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032276 · Cited by 74
Microarray Analysis of the Global Alterations in the Gene Expression in the Placentas From Cigarette-smoking Mothers
Huuskonen, P., Storvik, M., Reinisalo, M., Honkakoski, P., Rysä, J., Hakkola, J., & Pasanen, M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100376 · Cited by 75
Genetics of Endometriosis
Rahmioğlu, N., Montgomery, G. W., & Zondervan, K. T. (2015) · Women s Health · doi:10.2217/whe.15.41 · Cited by 73
Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review
Mokhosoev, I. M., Astakhov, D. V., Terentiev, A. A., & Moldogazieva, N. T. (2024) · Cells · doi:10.3390/cells13231958 · Cited by 78
Insights into assessing the genetics of endometriosis
Rahmioglu, N., Missmer, S. A., Montgomery, G. W., & Zondervan, K. T. (2012) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-012-0016-5 · Cited by 71
CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences
Timofeeva, M. N., Kropp, S., Sauter, W., Beckmann, L., Rosenberger, A., Illig, T., Jäger, B., Mittelstraß, K., Dienemann, H., Bartsch, H., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp102 · Cited by 70
Exploring Breast Cancer Estrogen Disposition: The Basis for Endocrine Manipulation
Lønning, P. E., Haynes, B. P., Straume, A. H., Dunbier, A. K., Helle, H., Knappskog, S., & Dowsett, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0043 · Cited by 67
Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women
The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0407-0 · Cited by 68
Mutations in the PTEN tumor gene and risk of endometriosis: a case–control study
Govatati, S., Kodati, V. L., Deenadayal, M., Chakravarty, B., Shivaji, S., & Bhanoori, M. (2013) · Human Reproduction · doi:10.1093/humrep/det387 · Cited by 65
Association between CYP2C19 polymorphism and depressive symptoms
Sim, S. C., Nordin, L., Andersson, T., Virding, S., Olsson, M., Pedersen, N. L., & Ingelman‐Sundberg, M. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31081 · Cited by 63
Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2C19 gene
Persson, A., Sim, S. C., Virding, S., Onishchenko, N. R., Schulte, G., & Ingelman‐Sundberg, M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.89 · Cited by 63
Inhibition of Estrogen-Mediated Mammary Tumorigenesis by Blueberry and Black Raspberry
Ravoori, S., Vadhanam, M. V., Aqil, F., & Gupta, R. C. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf205325p · Cited by 60
Protein Modifications as Potential Biomarkers in Breast Cancer
Jin, H., & Zangar, R. C. (2009) · Biomarker Insights · doi:10.4137/bmi.s2557 · Cited by 57
Genetics of endometriosis: a comprehensive review
Deiana, D., Gessa, S., Anardu, M., Daniilidis, A., Nappi, L., D’Alterio, M. N., Pontis, A., & Angioni, S. L. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1588244 · Cited by 56
Genetic Characterization of Endometriosis Patients: Review of the Literature and a Prospective Cohort Study on a Mediterranean Population
Angioni, S. L., D’Alterio, M. N., Coiana, A., Anni, F., Gessa, S., & Deiana, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051765 · Cited by 52
Estrogen pathway polymorphisms and mammographic density.
Dumas, I., & Diorio, C. (2011) · PubMed · Cited by 48
Anterior pituitary, sex hormones, and keratoconus: Beyond traditional targets
Karamichos, D., Escandon, P., Vasini, B., Nicholas, S. E., Van, L., Dang, D. H., Cunningham, R. L., & Riaz, K. M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101016 · Cited by 47
Pulmonary arterial hypertension: Sex matters
Dignam, J. P., Sharma, S., Stasinopoulos, I. A., & MacLean, M. R. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16277 · Cited by 46
High-density fine-mapping of a chromosome 10q26 linkage peak suggests association between endometriosis and variants close to CYP2C19
Painter, J. N., Nyholt, D. R., Morris, A. P., Zhao, Z., Henders, A. K., Lambert, A. W., Wallace, L. M., Martin, N. G., Kennedy, S., Treloar, S. A., et al. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.03.062 · Cited by 41
A Study on the Association of Cytochrome-P450 1A1 Polymorphism and Breast Cancer Risk in North Indian Women
Singh, V. K., Rastogi, N., Sinha, A., Kumar, A., Mathur, N., & Singh, M. P. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9264-2 · Cited by 41
Variation in Expression of Cytochrome P450 3A Isoforms and Toxicological Effects: Endo- and Exogenous Substances as Regulatory Factors and Substrates
Fujino, C., Sanoh, S., & Katsura, T. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b21-00332 · Cited by 40
Genetic polymorphisms in estrogen metabolism and breast cancer risk in case–control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians
Shimada, N., Iwasaki, M., Kasuga, Y., Yokoyama, S., Onuma, H., Nishimura, H., Kusama, R., Hamada, G. S., Nishimoto, I. N., Iyeyasu, H., et al. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2009.13 · Cited by 39
Similarity-based machine learning framework for predicting safety signals of adverse drug–drug interactions
Ibrahim, H. E., Kerdawy, A. M. E., Abdo, A., & Eldin, A. S. (2021) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2021.100699 · Cited by 39
Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy
The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk (2009) · International Journal of Cancer · doi:10.1002/ijc.24892 · Cited by 37
Mediated electron transfer efficiencies of Se(IV) bioreduction facilitated by meso-tetrakis (4-sulfonatophenyl) porphyrin
Zhao, R., Guo, J., Song, Y., Chen, Z., Lu, C., Han, Y., Li, H., Hou, Y., & He, Y. H. (2019) · International Biodeterioration & Biodegradation · doi:10.1016/j.ibiod.2019.104838 · Cited by 35
Synergism between Oral Estrogen Therapy and Cytochrome P450 3A5*1 Allele on the Risk of Venous Thromboembolism among Postmenopausal Women
Canonico, M., Bouaziz-Amar, É., Carcaillon‐Bentata, L., Verstuyft, C., Guiochon‐Mantel, A., Becquemont, L., & Scarabin, P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0450 · Cited by 35
Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer?
Obi, N., Vrieling, Heinz, & Chang-Claude (2011) · International Journal of Women s Health · doi:10.2147/ijwh.s7595 · Cited by 33
Inhibitory Effects of γ- and δ-Tocopherols on Estrogen-Stimulated Breast Cancer In Vitro and In Vivo
Bak, M. J., Gupta, S. D., Wahler, J., Lee, H. J., Li, X., Lee, M., Yang, C. S., & Suh, N. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0223 · Cited by 33
Recent data on intratumor estrogens in breast cancer
Lønning, P. E., Haynes, B. P., Straume, A. H., Dunbier, A. K., Helle, H., Knappskog, S., & Dowsett, M. (2011) · Steroids · doi:10.1016/j.steroids.2011.02.040 · Cited by 32
CYP2C19*17 Gain-of-Function Polymorphism Is Associated With Peptic Ulcer Disease
Musumba, C. O., Jorgensen, A., Sutton, L., Eker, D. V., Zhang, E., O’Hara, N., Carr, D. F., Pritchard, D. M., & Pirmohamed, M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.215 · Cited by 32
Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility
Treeck, O., Elemenler, E., Kriener, C., Horn, F., Springwald, A., Hartmann, A., & Ortmann, O. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.02.012 · Cited by 32
Pairwise Combinations of Estrogen Metabolism Genotypes in Postmenopausal Breast Cancer Etiology
Rebbeck, T. R., Troxel, A. B., Walker, A. H., Panossian, S., Gallagher, S., Shatalova, E. G., Blanchard, R. L., Norman, S. A., Bunin, G. R., DeMichele, A. M., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0800 · Cited by 29
Aromatase in human liver and its diseases
Hata, S., Miki, Y., Saito, R., Ishida, K., Watanabe, M., & Sasano, H. (2013) · Cancer Medicine · doi:10.1002/cam4.85 · Cited by 27
Breast density and polymorphisms in genes coding for CYP1A2 and COMT: the Multiethnic Cohort
Takata, Y., Maskarinec, G., & Marchand, L. L. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-30 · Cited by 25
Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancer
Tervasmäki, A., Winqvist, R., Jukkola‐Vuorinen, A., & Pylkäs, K. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-902 · Cited by 24
Fast steroid hormone metabolism assays with electrochemical liver microsomal bioreactor based on polydopamine encapsulated gold-graphene nanocomposite
Xu, X., Bai, G., Song, L., Zheng, Q., Yao, Y., Liu, S., & Yao, C. (2017) · Electrochimica Acta · doi:10.1016/j.electacta.2017.11.195 · Cited by 23
Vulnerability of marsh frog Pelophylax ridibundus to the typical wastewater effluents ibuprofen, triclosan and estrone, detected by multi-biomarker approach
Falfushynska, H., Gnatyshyna, L. L., Horyn, O., & Stoliar, O. B. (2017) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2017.07.004 · Cited by 23
Cancer outlier detection based on likelihood ratio test
Hu, J. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn372 · Cited by 22
Chemoprevention of mammary carcinogenesis by sustained systemic delivery of ellagic acid
Vadhanam, M. V., Ravoori, S., Aqil, F., & Gupta, R. C. (2011) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3283498e00 · Cited by 22
Common variants in the CYP2C19 gene are associated with susceptibility to endometriosis
Painter, J. N., Nyholt, D. R., Krause, L., Zhao, Z., Chapman, B. M., Zhang, C., Medland, S. E., Martin, N. G., Kennedy, S. M., Treloar, S. A., et al. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.04.015 · Cited by 20
Genic-intergenic polymorphisms of CYP1A genes and their clinical impact.
Kukal, S., Thakran, S., Kanojia, N., Yadav, S., Mishra, M. K., Guin, D., Singh, P., & Kukreti, R. (2023) · Gene · doi:10.1016/j.gene.2023.147171 · Cited by 15
Breast Cancer Risk, Fungicide Exposure and CYP1A1*2A Gene-Environment Interactions in a Province-Wide Case Control Study in Prince Edward Island, Canada
Ashley‐Martin, J., VanLeeuwen, J. A., Cribb, A. E., Andreou, P., & Guernsey, J. R. (2012) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph9051846 · Cited by 19
CYP17, Catechol-O-Methyltransferase, and Glutathione Transferase M1 Genetic Polymorphisms, Lifestyle Factors, and Breast Cancer Risk in Women on Prince Edward Island
Cribb, A. E., Knight, M. J., Guernsey, J., Dryer, D., Hender, K., Shawwa, A., Tesch, M., & Saleh, T. M. (2010) · The Breast Journal · doi:10.1111/j.1524-4741.2010.01025.x · Cited by 19
Potent Chemopreventive/Antioxidant Activity Detected in Common Spices of the Apiaceae Family
Jeyabalan, J., Aqil, F., Soper, L., Schultz, D. J., & Gupta, R. C. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1075051 · Cited by 18
Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk
Justenhoven, C. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00258 · Cited by 18
Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer
Schüler, S., Lattrich, C., Skrzypczak, M., Fehm, T. N., Ortmann, O., & Treeck, O. (2014) · Gene · doi:10.1016/j.gene.2014.05.066 · Cited by 17
Hepatotoxicity and gene expression down-regulation of CYP isozymes caused by renal ischemia/reperfusion in the rat
Wang, B., Li, Q., Li, J., Xie, X., Ao, Y., & Ai, Y.-X. (2009) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2008.12.010 · Cited by 17
6-Prenylnaringenin from Hops Disrupts ERα-Mediated Downregulation of CYP1A1 to Facilitate Estrogen Detoxification
Hitzman, R. T., Dunlap, T. L., Howell, C. E., Chen, S., Vollmer, G., Pauli, G. F., Bolton, J. L., & Dietz, B. M. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00194 · Cited by 16
Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank
Pisanu, C., Welander, N. Z., Rukh, G., Schiöth, H. B., & Mwinyi, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112234 · Cited by 15
Jujuboside A Attenuates Polycystic Ovary Syndrome Based on Estrogen Metabolism Through Activating AhR-mediated CYP1A2 Expression
Zhou, N., Lv, W., Chen, L., Chen, K., He, Q. P., Xie, G., Ma, J., Cao, Y., Zhang, B., & Zhou, X. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01511-0 · Cited by 15
The Pharmacogenomics of Sex Hormone Metabolism: Breast Cancer Risk in Menopausal Hormone Therapy
Justenhoven, C., Obazee, O. M., & Brauch, H. B. (2012) · Pharmacogenomics · doi:10.2217/pgs.11.144 · Cited by 15
Catecholoestrogens: possible role in systemic lupus erythematosus
Khan, W., Uddin, M., Khan, M. W. A., & Chabbra, H. S. (2009) · Rheumatology · doi:10.1093/rheumatology/kep168 · Cited by 15
The inhibition of tamoxifen on UGT2B gene expression and enzyme activity in rat liver contribute to the estrogen homeostasis dysregulation
Hao, Z., Xu, J., Zhao, H., Zhou, W., Liu, Z., He, S., Yin, X., Zhang, B., Wang, Z., & Zhou, X. (2022) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-022-00574-6 · Cited by 14
Genetic polymorphism of CYP2C19 and subcortical variability in the human adult brain
Stingl, J., Scholl, C., Bosch, J. E., & Viviani, R. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01591-5 · Cited by 14
Effect of CYP2C19 and CYP2D6 Genotype on Tamoxifen Treatment Outcome Indicates Endogenous and Exogenous Interplay
Sim, S. C., Lövrot, J., Lindh, J. D., Bergh, J. C. S., & Xie, H. (2018) · Pharmacogenomics · doi:10.2217/pgs-2018-0089 · Cited by 12
The effect of lacosamide on bone tissue in orchidectomised male albino Wistar rats
Simko, J., Fekete, S., Maláková, J., Kremláček, J., Horáček, J., Živná, H., Palička, V., & Živný, P. (2014) · Biomedical Papers · doi:10.5507/bp.2014.006 · Cited by 11
Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver
Haas, S., Merkelbach‐Bruse, S., Justenhoven, C., Brauch, H. B., & Fischer, H. (2009) · Pathology - Research and Practice · doi:10.1016/j.prp.2009.06.003 · Cited by 11
Oxidative Metabolism of Estrone Modified by Genistein and Bisphenol A in Rat Liver Microsomes
Gheldiu, A.-M., Popa, D., Loghin, F., & Vlase, L. (2015) · Biomedical and Environmental Sciences · doi:10.1016/s0895-3988(15)30115-x · Cited by 10
Role of cytochrome P450 2C19 polymorphisms and body mass index in endometriosis: A case–control study
Cardoso, J. V., Abrão, M. S., Berardo, P. T., Ferrari, R., Nasciutti, L. E., Machado, D. E., & Perini, J. A. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.10.027 · Cited by 10
The Role of Drug Metabolism in Drug Discovery
Bohnert, T., & Gan, L.-S. L. (2009) · doi:10.1002/9780470538951.ch5 · Cited by 10
Decoding the enigmatic estrogen paradox in pulmonary hypertension: delving into estrogen metabolites and metabolic enzymes
You, Q., Song, H., Zhu, Z., Wang, J., Wang, R., Du, M., Fu, Y., Yuan, J., & Tan, R. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00671-w · Cited by 9
Polymorphisms in the promoter region of estrogen receptor β gene in endometrial cancer
Lattrich, C., Häring, J., Schüler, S., Skrzypczak, M., Ortmann, O., & Treeck, O. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-3012-8 · Cited by 9
Evaluation of the epidemiological and prognosis significance of ESR2 rs3020450 polymorphism in ovarian cancer
Feng, Y., Peng, Z., Liu, W., Yang, Z., Shang, J., Cui, L., & Duan, F. (2019) · Gene · doi:10.1016/j.gene.2019.06.017 · Cited by 8
Genetic variability in estrogen disposition: Potential clinical implications for neuropsychiatric disorders
Grover, S., Talwar, P., Baghel, R., Kaur, H., Gupta, M., Gourie‐Devi, M., Bala, K., Sharma, S., & Kukreti, R. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31119 · Cited by 8
Activation of the YY1-UGT2B7 Axis Promotes Mammary Estrogen Homeostasis Dysregulation and Exacerbates Breast Tumor Metastasis
Xu, J., Zhou, Y., He, S., Wang, Y., Ma, J., Li, C., Liu, Z., & Zhou, X. (2024) · Drug Metabolism and Disposition · doi:10.1124/dmd.124.001640 · Cited by 7
Metabolic bioactivation of oestradiol-17β (E2β) in mouse colon epithelial cells bearing ApcMin mutation
Bellocq, D., Molina, J., Rathahao, E., Taché, S., Pierre, F. H. F., & Paris, A. (2010) · Steroids · doi:10.1016/j.steroids.2010.04.003 · Cited by 7
The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant
Justenhoven, C., Obazee, O. M., Winter, S., Couch, F. J., Olson, J. E., Hall, P. N., Hannelius, U., Li, J., Humphreys, K., Severi, G., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1827-1 · Cited by 7
Clinical, Cytogenetic and CYP1A1 exon-1 Gene Mutation Analysis of Beedi Workers in Vellore Region, Tamil Nadu
Sundaramoorthy, R., Srinivasan, V., Gujar, J., Sen, A., Sekar, N., & Gopalakrishnan, A. V. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.12.7555 · Cited by 7
Evaluation ofUGT1A1andSULT1A1polymorphisms with lipid levels in women with different hormonal status
Smiderle, L., Galvão, A. C. S., Fontana, C., Wender, M. C. O., Agnes, G., Giovenardi, M., Hutz, M. H., & Almeida, S. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.493248 · Cited by 7
Pharmacogenomics of Cytochrome P450 Dependent Metabolism of Endogenous Compounds: Implications for Behavior, Psychopathology and Treatment
Persson, A. (2014) · Journal of Pharmacogenomics & Pharmacoproteomics · doi:10.4172/2153-0645.1000127 · Cited by 7
CYP2C19 metabolic estrogen phenotypes and endometriosis risk in Brazilian women
Perini, J. A., Machado, D. E., Cardoso, J. V., Fernandes, V. C., Struchiner, C. J., & Suarez‐Kurtz, G. (2023) · Clinics · doi:10.1016/j.clinsp.2023.100176 · Cited by 6
2′-Deoxyguanosine as a surrogate trapping agent for DNA reactive drug metabolites
Häkkinen, M. R., Laine, J., Juvonen, R. O., Auriola, S. O. K., Häyrinen, J., & Pasanen, M. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.08.020 · Cited by 5
Meta-analysis of CYP2E1 polymorphisms in liver carcinogenesis
Fu, P., Yang, F., Li, B., Zhang, B., Guan, L., Sheng, J., Ye, Y., Wang, Z., Li, P., Li, X., et al. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.08.114 · Cited by 5
Breast cancer susceptibility genes in estrogen metabolizing pathway in a southern Indian population
Francis, A. M., Ramya, R., Ganesan, N., Kumarasamy, P., Paul, S. F. D., Munirajan, A. K., & Divya, M. (2018) · Meta Gene · doi:10.1016/j.mgene.2018.12.009 · Cited by 5
Chemopreventive Effects of Berries and Berry Components in Animal Models: Prevention of Estrogen-Mediated Mammary Tumors in ACI Rats by Berries
Aiyer, H. S., Ravoori, S., & Gupta, R. C. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7554-6_9 · Cited by 5
CYP2C19-rs4986893 confers risk to major depressive disorder and bipolar disorder in the Han Chinese population whereas ABCB1-rs1045642 acts as a protective factor
Zhang, T., Rao, Q., Lin, K., He, Y., Cai, J., Yang, M., Xu, Y., Hou, L., Lin, Y., & Liu, H. (2023) · BMC Psychiatry · doi:10.1186/s12888-022-04514-w · Cited by 4
Chromatographic analysis and decomposition product characterization of compound SR16157 (NSC 732011)
Wang, J., Chunyang, Wang, E., Li, S., Zaveri, N. T., & Liu, P. (2007) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2007.08.015 · Cited by 3
CYP2C19 expression modulates affective functioning and hippocampal subiculum volume—a large single-center community-dwelling cohort study
Grosu, C., Trofimova, O., Gholam‐Rezaee, M., Strippoli, M. F., Kherif, F., Lutti, A., Preisig, M., Draganski, B., & Eap, C. B. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02091-w · Cited by 3
Metabolism of testosterone and progesterone by cytochrome P450 2C19 allelic variants
Takeji, S., Okada, M., Hayashi, S., Kanamaru, K., Uno, Y., Imaishi, H., & Uno, T. (2023) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2378 · Cited by 3
Icb-1 gene polymorphism rs1467465 is associated with susceptibility to ovarian cancer
Schüler, S., Lattrich, C., Skrzypczak, M., Fehm, T. N., Ortmann, O., & Treeck, O. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-42 · Cited by 3
CYP2C19 gene polymorphisms among Moroccan patients with breast cancer disease: A case-control study
Elouilamine, E., Akil, S. E., Aznag, F. Z., & Izaabel, E. H. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100610 · Cited by 2
Molecular Genetics of Endometriosis
Painter, J. N., Zondervan, K. T., Missmer, S. A., & Montgomery, G. W. (2011) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0021473 · Cited by 2
The Promise of Individualized Therapy
Oettel, M. (2010) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse336 · Cited by 2
The effects of tamoxifen and its metabolites on circulating estrogen metabolites among pre- and postmenopausal women
Ghosh, R., Pfeiffer, R. M., Ramin, C. A., Xu, X., Turner, P. C., He, X., Troisi, R. J., Fan, S., Gierach, G. L., & Dallal, C. M. (2025) · Steroids · doi:10.1016/j.steroids.2025.109736 · Cited by 1

Authors: Cribb, A. E., Knight, M. J., Dryer, D., Guernsey, J., Hender, K., Tesch, M., & Saleh, T. M.
Affiliations: University of Prince Edward Island (CA)
2Queen Elizabeth Hospital, Charlottetown, Prince Edward Island, Canada; and
Dalhousie University (CA)
ORCID: Cribb, Alastair E.
Saleh, Tarek M.
Venue: Cancer Epidemiology, Biomarkers & Prevention
Publisher: American Association for Cancer Research (AACR)
Published: 2006-03-01
Volume: 15
Issue: 3
Pages: 551-558
ISSN: 1055-9965 (ISSN-L)
1538-7755
DOI: 10.1158/1055-9965.epi-05-0801
OpenAlex: W2141239229
Cited by: 118
References: 70
Citations by year: 2025: 3 · 2024: 5 · 2023: 8 · 2022: 7 · 2021: 6 · 2020: 3 · 2019: 6 · 2018: 3 · 2017: 4 · 2016: 2 · 2015: 5 · 2014: 8 · 2013: 7 · 2012: 8
FWCI: 7.31
Type: journal article
Language: en
Open access: closed
Locations: Cancer Epidemiology Biomarkers & Prevention (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
Keywords: estrogen metabolism, cytochrome P450 polymorphisms, breast cancer risk, 2-hydroxyestrone, 4-hydroxyestrone, 16α-hydroxyestrone, CYP1A2, CYP1A1, CYP1B1, CYP2C19, CYP3A5, liver microsomes, genetic variation
MeSH terms: Breast Neoplasms, Chromatography, High Pressure Liquid, Cytochrome P-450 Enzyme System, Estrone, Female, Humans, Mixed Function Oxygenases, Hydroxylation, Microsomes, Liver, Oxidation-Reduction, Sensitivity and Specificity, Tumor Cells, Cultured, Biomarkers, Tumor, Cytochrome P-450 CYP1A1, Cytochrome P-450 CYP1A2, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Role of Polymorphic Human Cytochrome P450 Enzymes in Estrone Oxidation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks